India Pesticides Limited (IPL.NS)
Lucknow, TN, IN
India Pesticides Limited engages in the agri chemicals business in India. The company manufactures, sells, and distributes insecticides, fungicides, herbicide, and various agrochemical products, as well as active pharmaceutical ingredients for use in pharmaceutical drugs. The company also exports its products to approximately 35 countries. India Pesticides Limited was incorporated in 1984 and is based in Lucknow, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.65% | +8.05% | +18.37% | +13.05% | +0.23% | +1.98% | +2.73% | -21.18% | -48.62% | -48.62% | -48.62% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+27.6% ★ Q1'26: +28.6% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+45.3% ★ Q1'26: +40.0% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+1.3% Q1'26: +16.2% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+14.4% ★ Q1'26: +13.7% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+11.0% ★ Q1'26: +11.8% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.4% Q1'26: +0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.64× ★ Q1'26: 0.66× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
7.09B
est: 7.16B (-1.0%)
|
8.85B
est: 9.23B (-4.1%)
|
6.79B
est: 6.99B (-3.0%)
|
8.29B
est: 9.40B (-11.8%)
|
10.11B
10.11B – 10.11B
+7.6% YoY
|
| EBITDA |
2.27B
est: 1.67B (+36.3%)
|
2.08B
est: 2.15B (-2.8%)
|
1.02B
est: 1.63B (-37.4%)
|
1.34B
est: 2.19B (-38.5%)
|
2.35B
2.35B – 2.35B
+7.6% YoY
|
| EBIT |
2.18B
est: 1.55B (+40.7%)
|
1.97B
est: 2.00B (-1.5%)
|
866.80M
est: 1.52B (-42.8%)
|
1.16B
est: 2.04B (-43.0%)
|
2.19B
2.19B – 2.19B
+7.6% YoY
|
| Net Income |
1.58B
est: 1.58B (-0.3%)
|
1.43B
est: 1.72B (-16.8%)
|
601.70M
est: 637.61M (-5.6%)
|
821.80M
est: 1.08B (-23.8%)
|
1.19B
1.19B – 1.19B
+10.6% YoY
|
| SGA |
546.19M
est: 439.80M (+24.2%)
|
414.45M
est: 566.80M (-26.9%)
|
274.30M
est: 429.50M (-36.1%)
|
588.70M
est: 577.24M (+2.0%)
|
621.09M
621.09M – 621.09M
+7.6% YoY
|
| EPS |
13.82
est: 13.80 (+0.1%)
|
12.44
est: 15.00 (-17.1%)
|
5.24
est: 5.55 (-5.7%)
|
7.16
est: 9.40 (-23.8%)
|
10.40
10.40 – 10.40
+10.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | B+ | 3/5 | 1/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 91.2K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 19.9K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kuruba Adeppa | Whole-time Director | 2M | — |
| Udaya Bhaskar Mantripragada | Whole-time Director | 2M | — |
| Anand Swarup Agarwal | Founder, Promoter & Non-Executive Director | 800.0K | male |
| Dheeraj Kumar Jain | Chief Executive Officer | — | male |
| Narendra Dev Nath Ojha | Company Secretary & Compliance Officer | — | male |
| Satya Prakash Gupta | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IPL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
